Genetic modification of risk assessment based on staging of preclinical type 1 diabetes in siblings of affected children.

MLA

Mrena, S., et al. “Genetic Modification of Risk Assessment Based on Staging of Preclinical Type 1 Diabetes in Siblings of Affected Children.” The Journal of Clinical Endocrinology and Metabolism, vol. 88, no. 6, June 2003, pp. 2682–89. EBSCOhost, https://doi.org/10.1210/jc.2002-020644.

APA

Mrena, S., Savola, K., Kulmala, P., Reijonen, H., Ilonen, J., Akerblom, H. K., & Knip, M. (2003). Genetic modification of risk assessment based on staging of preclinical type 1 diabetes in siblings of affected children. The Journal of Clinical Endocrinology and Metabolism, 88(6), 2682–2689. https://doi.org/10.1210/jc.2002-020644

Chicago

Mrena, S, K Savola, P Kulmala, H Reijonen, J Ilonen, H K Akerblom, and M Knip. 2003. “Genetic Modification of Risk Assessment Based on Staging of Preclinical Type 1 Diabetes in Siblings of Affected Children.” The Journal of Clinical Endocrinology and Metabolism 88 (6): 2682–89. doi:10.1210/jc.2002-020644.